CC-42344 + Placebo
Phase 2Completed 0 watching 0 views this week⚡ Active
44
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Influenza A
Conditions
Influenza A
Trial Timeline
Nov 25, 2023 → Jul 18, 2024
NCT ID
NCT06160531About CC-42344 + Placebo
CC-42344 + Placebo is a phase 2 stage product being developed by hVIVO for Influenza A. The current trial status is completed. This product is registered under clinical trial identifier NCT06160531. Target conditions include Influenza A.
Hype Score Breakdown
Clinical
17
Activity
12
Company
2
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT06160531 | Phase 2 | Completed |
Competing Products
20 competing products in Influenza A